ACE2 is highly expressed in various cancers including, squamous cell/adenosquamous carcinoma, endometrial carcinoma, colorectal, breast, prostate and lung cancer [36–38] as well as prostate adenocarcinoma [39]. Here, ACE2 is linked to lung carcinoma.